Edwards Lifesciences Corporation vs ResMed Inc., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where EW and RMD diverge most: on return on invested capital, EW reads 6.5% and RMD reads 21.1%; on implied growth (priced in), EW reads +24.9% and RMD reads +8.5%. The rest of the comparable metrics sit closer together. On valuation, today's EW price has a different growth bar priced in than RMD (+24.9% implied for EW vs +8.5% for RMD); the higher figure is the steeper assumption to clear, not a better or worse stock. What EW's price implies is a bet that sits within the historical range (whole-company basis). What RMD's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | EW | RMD |
|---|---|---|
| Price | $85.23 | $230.14 |
| Market cap | $49.2B | $33.5B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Mature |
| Implied growth (priced in) | +24.9% | +8.5% |
| P/E | 49.0 | 22.1 |
| P/B | 4.59 | 5.09 |
| P/S | 7.56 | 5.93 |
| EV/EBITDA | 29.1 | 15.7 |
| Revenue growth | +14.6% | +9.9% |
| Gross margin | 77.5% | 58.8% |
| Operating margin | 29.5% | 30.7% |
| Net margin | 15.4% | 26.9% |
| Return on equity | 9.4% | 23.1% |
| Return on assets | 7.3% | 17.0% |
| Return on invested capital | 6.5% | 21.1% |
| FCF yield | 2.9% | 4.9% |
| Dividend yield | — | 1.0% |
| Debt / equity | 0.06 | 0.10 |
| Current ratio | 4.52 | 3.10 |
| Altman Z (solvency) | 8.55 | 8.32 |
| Piotroski F (quality) | 7 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.